VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Post by bcman79on Oct 27, 2020 10:59pm

152 Views

Post# 31793691

From Yahoo Finance

VPT Share Statistics

Avg Vol (3 month) 3	995.88k
Avg Vol (10 day) 3	1.29M
Shares Outstanding 5	69.73M
Float	69M
% Held by Insiders 1	3.49%
% Held by Institutions 1	0.00%
Shares Short (Oct. 15, 2020) 4	132.75k
Short Ratio (Oct. 15, 2020) 4	0.05
Short % of Float (Oct. 15, 2020) 4	N/A
Short % of Shares Outstanding (Oct. 15, 2020) 4	0.19%
Shares Short (prior month Sep. 15, 2020) 4	16.74k